Rami Salah-Eddin Komrokji MD

Hematology•Tampa, FL

Hematologic Oncology

Professor of Oncologic Sciences

Request appointment

12902 magnolia driveTampaTampa, FL 33612
Book by Phone+1(754) 335-0941

Overview of Dr. Komrokji

Dr. Rami Komrokji is a hematologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Jordan Faculty of Medicine and has been in practice 15 years. He specializes in hematologic oncology and is experienced in hematologic oncology, namely acute myeloid leukemia, Myelodysplastic syndromes, and myeloproliferative neoplasm. He is member of NCCN MDS committee. He has authored more than 200 peer reviewed papers and lectured world wide about those diseases.

Education & Training

University of Rochester Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
St Vincent Charity Medical CenterResidency, Internal Medicine, 1999 - 2001
Columbia Saint Luke's Medical CenterResidency, Internal Medicine, 1998 - 1999
University of Jordan Faculty of MedicineClass of 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

FL State Medical License 2008 - 2027
OH State Medical License 1999 - 2016
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification PathNet, Cerner Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2014, 2016-2017

Clinical Trials

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Start of enrollment: 2003 Aug 27
COMPLETED
PHASE3
S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia Start of enrollment: 2007 Nov 15
COMPLETED
PHASE2
A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia
WITHDRAWN
PHASE2

Publications & Presentations

PubMed

Hematologic responses achieved with luspatercept in higher-risk myelodysplastic syndromes.
Daniel Leonard, David A Sallman, Kelly Pugh, Christopher Bell, Najila H Al Ali
Blood Advances. 2026-08-11
Clinical features and outcomes of MPN with concurrent MPL and JAK2/CALR Mutations.
Yu-Han Chen, Shruti Gajjar, Victor You, Rami Komrokji, Valentina Nardi
Blood Neoplasia. 2026-08-01
CMML is in the eye of the be-WHO-lder: interrogating the newly proposed entity of oligomonocytic CMML: MDS or CMML?
Rami S Komrokji, Zena Komrokji, Najla H Al Ali, Zhuoer Xie, Onyee Chan
Blood Neoplasia. 2026-08-01

Journal Articles

Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)
Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Sanam Loghavi, Jaroslaw P Maciejewski, Blood

Abstracts/Posters

Hypomethylating Agent and Venetoclax Combination Yields Comparable Outcomes to CPX-351 in Newly Diagnosed Acute Myeloid Leukemia
Rami S. Komrokji, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
WHO-Defined Chronic Myelomonocytic Leukemia-2 (CMML-2) Patients Rapidly Progress to AML Suggesting This Entity Represents a Transitory Clinical State
Rami S. Komrokji, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Bromodomain and Extra Terminal Domain (BET) Inhibitors Sensitize Chronic Myelomonocytic Leukemia (CMML) to PIM Inhibition Via Downregulation of Mir-33a
Rami S. Komrokji, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

MPN Tumor Board: Application of Novel Agents for the Treatment of Polycythemia Vera and Myelofibrosis
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
SF3B1 Clone Size Is an Independent Determinant for Overall Survival and Response to Treatment in Patients with Myelodysplastic Syndrome
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Geno-Clinical Model to Aid in the Diagnosis of Myelodysplastic Syndrome (MDS) Versus Chronic Myelomonocytic Leukemia (CMML)
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Geron Announces Presentations at ASCO and EHA Underscoring RYTELO® (Imetelstat) Efficacy and Safety Across Range of LR-MDS Patients, and Showcasing Momentum of Myelofibrosis ProgramMay 28th, 2025
Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (Imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior TherapiesDecember 10th, 2024
Geron Announces New Data to Be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (Imetelstat) in Myeloid Hematologic MalignanciesNovember 5th, 2024

Committees

Member, NCCN MDS Guidelines committee 2008 - Present

Professional Memberships

American Society of Hematology - ASH
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Kansas City Preferred-Care Blue PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment